Belinta 90mg Tablet
Belinta 90mg Tablet belongs to a group of medicines called antiplatelet or blood thinners. It reduces the formation of harmful blood clots in blood vessels, which helps to prevent heart attacks or strokes in people with heart disease.
Belinta 90mg Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Belinta 90mg Tablet belongs to a group of medicines called antiplatelet or blood thinners. It reduces the formation of harmful blood clots in blood vessels, which helps to prevent heart attacks or strokes in people with heart disease.
Belinta 90mg Tablet belongs to a group of medicines called antiplatelet or blood thinners. It reduces the formation of harmful blood clots in blood vessels, which helps to prevent heart attacks or strokes in people with heart disease.
Belinta 90mg Tablet is also used to treat people with a recent heart attack or severe heart-related chest pain (unstable angina) who have undergone stenting of the heart. It helps to prevent serious heart-related problems like having another heart attack, stroke, or formation of blood clots in stents in such people.
Your doctor will also prescribe aspirin, another antiplatelet medicine, along with this medicine. Belinta 90mg Tablet may be taken with or without food and should be taken regularly at the same time each day. It is important to keep taking it even if you feel well. If you stop taking this medicine, it may increase your chances of having another heart attack or stroke.
The most common side effects of this medicine are dyspnea (breathlessness) and bleeding. If you cut or injure yourself, it may take longer than usual for the bleeding to stop. Such episodes of bleeding are usually mild and resolve on their own. Mild breathlessness caused by this medicine usually resolves on its own with continued treatment. Let your doctor know if bleeding persists or if the breathlessness worsens or does not go away.
Belinta 90mg Tablet is not suitable for some people. Do not take it if you are bleeding from anywhere in the body, such as a stomach ulcer or bleeding within the brain. It is also not recommended for people with liver diseases. Before using the medicine, inform your doctor of any such problems.
03Uses
Heart attack
Prevention of heart attack and stroke
Unstable angina
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Belinta 90mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
05How It Works
Belinta 90mg Tablet is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
06What If You Miss A Dose?
Q: What if you forget to take Belinta Tablet?
A: If you miss a dose of Belinta 90mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Prevention of heart attack and stroke
Belinta 90mg Tablet is an antiplatelet medicine or blood thinner. It prevents blood from clotting inside the veins and arteries, helping the blood flow freely around your body and preventing a heart attack or stroke (deep vein thrombosis or pulmonary embolism). To achieve maximum benefits, take this medicine regularly and make appropriate lifestyle changes. It is often prescribed with a low dose of aspirin, which also helps prevent blood from clotting.
08Side Effects
Bleeding
Breathlessness
09Safety Information
Alcohol:CAUTION
Caution is advised when consuming alcohol with Belinta 90mg Tablet. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Belinta 90mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Information regarding the use of Belinta 90mg Tablet during breastfeeding is not available. Please consult your doctor.
Driving:CONSULT YOUR DOCTOR
It is not known whether Belinta 90mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.Dizziness, confusion, vertigo, and syncope have been reported in some patients. If you experience such symptoms, be cautious while driving or using machines.
Kidney:SAFE IF PRESCRIBED
Belinta 90mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Belinta 90mg Tablet is recommended.Limited information is available on the use of Belinta 90mg Tablet in renal dialysis patients.
Liver:SAFE IF PRESCRIBED
Belinta 90mg Tablet is safe to use in patients with liver disease. No dose adjustment of Belinta 90mg Tablet is recommended.Use of Belinta 90mg Tablet is not recommended in patients with severe liver disease.
10Drug Tips
For best results, take it at the same time every day.
Belinta 90mg Tablet increases your risk of bleeding. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
Do not discontinue using the medicine without consulting your doctor, as this may increase your chances of having another heart attack or stroke.
If you are scheduled to undergo surgery or dental treatment, you may be asked to temporarily stop taking Belinta 90mg Tablet.
You may experience shortness of breath in the initial weeks of therapy. Notify your doctor if it becomes worse or persists for long.
References
Sources and references
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72.
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 351-52.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1359-60.
Ticagrelor. Luton, Bedfordshire: AstraZeneca UK Limited; 2010 [revised 15th Nov. 2018]. [Accessed 24 Jan. 2019] (online) Available from: View
Ticagrelor. Wilmington, Delaware: AstraZeneca LP; 2015. [Accessed 20 Mar. 2019] (online) Available from: View
Ticagrelor. Wilmington, Delaware: AstraZeneca LP; 2011 [revised Sep. 2015]. [Accessed 19 Mar. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from: View
Ticagrelor [Package Insert]. Ahmedabad, Gujarat: Torrent Pharmaceuticals Ltd.; 2020. [Accessed 07 Aug. 2023]. (online) Available from: View
Ticagrelor [Product Monograph]. Mississauga, Ontario: AstraZeneca Canada Inc.; 2024. [Accessed Oct. 10, 2024] (online) Available from: View
